Overexpression of CD39 in mouse airways promotes bacteria-induced inflammation

Journal of Immunology

Volumn 189, Issue 4, 2012, Pages 1966-1974

  Théâtre, Emilie ^a   Frederix, Kim ^a   Guilmain, William ^a   Delierneux, Céline ^a   Lecut, Christelle ^a   Bettendorff, Lucien ^a   Bours, Vincent ^a   Oury, Cécile ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CD39 ANTIGEN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2X7 RECEPTOR; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BACTERIAL CLEARANCE; CD8+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; GENE OVEREXPRESSION; IMMUNE RESPONSE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFLAMMATION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; APYRASE; BACTERIAL INFECTIONS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; PNEUMONIA; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84864803475     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102600     Document Type: Article

References (47)

1. Volonté, C., and N. D'Ambrosi. 2009. Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters. FEBS J. 276: 318-329.
2. Lazarowski, E. R., R. Tarran, B. R. Grubb, C. A. van Heusden, S. Okada, and R. C. Boucher. 2004. Nucleotide release provides a mechanism for airway surface liquid homeostasis. J. Biol. Chem. 279: 36855-36864. (Pubitemid 39129034)
3. Lazarowski, E. R., and R. C. Boucher. 2009. Purinergic receptors in airway epithelia. Curr. Opin. Pharmacol. 9: 262-267.
4. Lazarowski, E. R., R. C. Boucher, and T. K. Harden. 2003. Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol. Pharmacol. 64: 785-795. (Pubitemid 37153046)
5. Burnstock, G. 2007. Purine and pyrimidine receptors. Cell. Mol. Life Sci. 64: 1471-1483. (Pubitemid 46954150)
6. Burch, L. H., and M. Picher. 2006. E-NTPDases in human airways: Regulation and relevance for chronic lung diseases. Purinergic Signal. 2: 399-408.
7. Polosa, R., and M. R. Blackburn. 2009. Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease. Trends Pharmacol. Sci. 30: 528-535.
8. Idzko, M., H. Hammad, M. van Nimwegen, M. Kool, M. A. Willart, F. Muskens, H. C. Hoogsteden, W. Luttmann, D. Ferrari, F. Di Virgilio, et al. 2007. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat. Med. 13: 913-919. (Pubitemid 47222044)
9. Esther, C. R., Jr., N. E. Alexis, M. L. Clas, E. R. Lazarowski, S. H. Donaldson, C. M. Ribeiro, C. G. Moore, S. D. Davis, and R. C. Boucher. 2008. Extracellular purines are biomarkers of neutrophilic airway inflammation. Eur. Respir. J. 31: 949-956.
10. Mortaz, E., G. Folkerts, F. P. Nijkamp, and P. A. Henricks. 2010. ATP and the pathogenesis of COPD. Eur. J. Pharmacol. 638: 1-4.
11. Lucattelli, M., S. Cicko, T. Müller, M. Lommatzsch, G. De Cunto, S. Cardini, W. Sundas, M. Grimm, R. Zeiser, T. Dürk, et al. 2011. P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysema. Am. J. Respir. Cell Mol. Biol. 44: 423-429.
12. Cicko, S., M. Lucattelli, T. Müller, M. Lommatzsch, G. De Cunto, S. Cardini, W. Sundas, M. Grimm, R. Zeiser, T. Dürk, et al. 2010. Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema. J. Immunol. 185: 688-697.
13. Eckle, T., L. Füllbier, M. Wehrmann, J. Khoury, M. Mittelbronn, J. Ibla, P. Rosenberger, and H. K. Eltzschig. 2007. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J. Immunol. 178: 8127-8137. (Pubitemid 46898085)
14. Eltzschig, H. K., J. C. Ibla, G. T. Furuta, M. O. Leonard, K. A. Jacobson, K. Enjyoji, S. C. Robson, and S. P. Colgan. 2003. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J. Exp. Med. 198: 783-796. (Pubitemid 37087777)
15. Künzli, B. M., P. Nuhn, K. Enjyoji, Y. Banz, R. N. Smith, E. Csizmadia, D. Schuppan, P. O. Berberat, H. Friess, and S. C. Robson. 2008. Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice. Gastroenterology 134: 292-305. (Pubitemid 350309325)
16. Neshat, S., M. deVries, A. R. Barajas-Espinosa, L. Skeith, S. P. Chisholm, and A. E. Lomax. 2009. Loss of purinergic vascular regulation in the colon during colitis is associated with upregulation of CD39. Am. J. Physiol. Gastrointest. Liver Physiol. 296: G399-G405.
17. Reutershan, J., I. Vollmer, S. Stark, R. Wagner, K. C. Ngamsri, and H. K. Eltzschig. 2009. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. FASEB J. 23: 473-482.
18. Theatre, E., L. de Leval, L. Bettendorf, V. Bours, and C. Oury. 2008. Overexpression of airway CD39 in transgenic mice enhances lipopolysaccharide induced inflammation. Purinergic Signal. 4: S113.
19. Zhu, Z., R. J. Homer, Z. Wang, Q. Chen, G. P. Geba, J. Wang, Y. Zhang, and J. A. Elias. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103: 779-788. (Pubitemid 29152623)
20. Holvoet, P., S. Danloy, and D. Collen. 1997. Role of the carboxy-terminal domain of human apolipoprotein AI in high-density-lipoprotein metabolism - a study based on deletion and substitution variants in transgenic mice. Eur. J. Biochem. 245: 642-647. (Pubitemid 27223896)
21. Gangolf, M., P. Wins, M. Thiry, B. El Moualij, and L. Bettendorff. 2010. Thiamine triphosphate synthesis in rat brain occurs in mitochondria and is coupled to the respiratory chain. J. Biol. Chem. 285: 583-594.
22. Enjyoji, K., J. Sévigny, Y. Lin, P. S. Frenette, P. D. Christie, J. S. Esch, II, M. Imai, J. M. Edelberg, H. Rayburn, M. Lech, et al. 1999. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat. Med. 5: 1010-1017. (Pubitemid 29439571)
23. Dwyer, K. M., S. C. Robson, H. H. Nandurkar, D. J. Campbell, H. Gock, L. J. Murray-Segal, N. Fisicaro, T. B. Mysore, E. Kaczmarek, P. J. Cowan, and A. J. d'Apice. 2004. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J. Clin. Invest. 113: 1440-1446. (Pubitemid 39071699)
24. Hülsmann, M., P. Nickel, M. Kassack, G. Schmalzing, G. Lambrecht, and F. Markwardt. 2003. NF449, a novel picomolar potency antagonist at human P2X1 receptors. Eur. J. Pharmacol. 470: 1-7. (Pubitemid 36638618)
25. King, B. F. 2007. Novel P2X7 receptor antagonists ease the pain. Br. J. Pharmacol. 151: 565-567. (Pubitemid 47016293)
26. Théâtre, E., V. Bours, and C. Oury. 2009. A P2X ion channel-triggered NF-kappaB pathway enhances TNF-alpha-induced IL-8 expression in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 41: 705-713.
27. Oury, C., K. Daenens, H. Hu, E. Toth-Zsamboki, M. Bryckaert, and M. F. Hoylaerts. 2006. ERK2 activation in arteriolar and venular murine thrombosis: platelet receptor GPIb vs. P2X. J. Thromb. Haemost. 4: 443-452.
28. Desvignes, L., and J. D. Ernst. 2009. Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity 31: 974-985.
29. Koeppen, M., F. Di Virgilio, E. T. Clambey, and H. K. Eltzschig. 2011. Purinergic regulation of airway inflammation. Subcell. Biochem. 55: 159-193.
30. Müller, T., R. P. Vieira, M. Grimm, T. Dürk, S. Cicko, R. Zeiser, T. Jakob, S. F. Martin, B. Blumenthal, S. Sorichter, et al. 2011. A potential role for P2X7R in allergic airway inflammation in mice and humans. Am. J. Respir. Cell Mol. Biol. 44: 456-464.
31. Riteau, N., P. Gasse, L. Fauconnier, A. Gombault, M. Couegnat, L. Fick, J. Kanellopoulos, V. F. Quesniaux, S. Marchand-Adam, B. Crestani, et al. 2010. Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. Am. J. Respir. Crit. Care Med. 182: 774-783.
32. Ferrari, D., C. Pizzirani, E. Adinolfi, R. M. Lemoli, A. Curti, M. Idzko, E. Panther, and F. Di Virgilio. 2006. The P2X7 receptor: a key player in IL-1 processing and release. J. Immunol. 176: 3877-3883. (Pubitemid 44264361)
33. Weber, F. C., P. R. Esser, T. Müller, J. Ganesan, P. Pellegatti, M. M. Simon, R. Zeiser, M. Idzko, T. Jakob, and S. F. Martin. 2010. Lack of the purinergic receptor P2X(7) results in resistance to contact hypersensitivity. J. Exp. Med. 207: 2609-2619.
34. Heiss, K., N. Jänner, B. Mähnss, V. Schumacher, F. Koch-Nolte, F. Haag, and H. W. Mittrücker. 2008. High sensitivity of intestinal CD8+ T cells to nucleotides indicates P2X7 as a regulator for intestinal T cell responses. J. Immunol. 181: 3861-3869.
35. Labasi, J. M., N. Petrushova, C. Donovan, S. McCurdy, P. Lira, M. M. Payette, W. Brissette, J. R. Wicks, L. Audoly, and C. A. Gabel. 2002. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J. Immunol. 168: 6436-6445. (Pubitemid 34620068)
36. Taylor, S. R., M. Gonzalez-Begne, S. Dewhurst, G. Chimini, C. F. Higgins, J. E. Melvin, and J. I. Elliott. 2008. Sequential shrinkage and swelling underlie P2X7-stimulated lymphocyte phosphatidylserine exposure and death. J. Immunol. 180: 300-308.
37. Lecut, C., K. Frederix, D. M. Johnson, C. Deroanne, M. Thiry, C. Faccinetto, R. Marée, R. J. Evans, P. G. Volders, V. Bours, and C. Oury. 2009. P2X1 ion channels promote neutrophil chemotaxis through Rho kinase activation. J. Immunol. 183: 2801-2809.
38. Chen, Y., R. Corriden, Y. Inoue, L. Yip, N. Hashiguchi, A. Zinkernagel, V. Nizet, P. A. Insel, and W. G. Junger. 2006. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314: 1792-1795. (Pubitemid 44969094)
39. Junger, W. G. 2011. Immune cell regulation by autocrine purinergic signalling. Nat. Rev. Immunol. 11: 201-212.
40. Woehrle, T., L. Yip, A. Elkhal, Y. Sumi, Y. Chen, Y. Yao, P. A. Insel, and W. G. Junger. 2010. Pannexin-1 hemichannel-mediated ATP release together with P2X1 and P2X4 receptors regulate T-cell activation at the immune synapse. Blood 116: 3475-3484.
41. Saetta, M., A. Di Stefano, G. Turato, F. M. Facchini, L. Corbino, C. E. Mapp, P. Maestrelli, A. Ciaccia, and L. M. Fabbri. 1998. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 157: 822-826.
42. Bours, M. J., E. L. Swennen, F. Di Virgilio, B. N. Cronstein, and P. C. Dagnelie. 2006. Adenosine 59-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 112: 358-404. (Pubitemid 44486409)
43. Spicuzza, L., G. Di Maria, and R. Polosa. 2006. Adenosine in the airways: implications and applications. Eur. J. Pharmacol. 533: 77-88. (Pubitemid 43340006)
44. Schepp, C. P., and J. Reutershan. 2008. Bench-to-bedside review: adenosine receptors-promising targets in acute lung injury? Crit. Care 12: 226.
45. Blackburn, M. R., C. G. Lee, H. W. Young, Z. Zhu, J. L. Chunn, M. J. Kang, S. K. Banerjee, and J. A. Elias. 2003. Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. J. Clin. Invest. 112: 332-344. (Pubitemid 38063762)
46. Blackburn, M. R. 2003. Too much of a good thing: adenosine overload in adenosine-deaminase-deficient mice. Trends Pharmacol. Sci. 24: 66-70. (Pubitemid 36135878)
47. Pedroza, M., D. J. Schneider, H. Karmouty-Quintana, J. Coote, S. Shaw, R. Corrigan, J. G. Molina, J. L. Alcorn, D. Galas, R. Gelinas, and M. R. Blackburn. 2011. Interleukin-6 contributes to inflammation and remodeling in a model of adenosine mediated lung injury. PLoS ONE 6: e22667.